We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAE... ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures. Show more
ENDRA’s IP Portfolio Reaches Milestone of 80 Issued Patents ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the issuance of five new...
Conference call begins at 4:30 p.m. Eastern time today ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reports financial results for the...
ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the company will report financial results for the three months and...
King's College Hospital in London Leads UK Introduction of ENDRA Liver System ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that it...
Code Complements Important Advancements by the Pharmaceutical Industry and Revised Medical Association Guidelines ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced...
Global Intellectual Property Portfolio Expands to 74 Issued Patents ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the issuance of...
Intellectual Property Portfolio Now Stands at 71 Globally Issued Patents ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the...
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will be participating in The Benchmark Company’s 12th Annual...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0747 | 29.6428571429 | 0.252 | 0.379899 | 0.2422 | 157391 | 0.30762862 | CS |
4 | -0.0533 | -14.0263157895 | 0.38 | 0.396 | 0.221 | 124254 | 0.29935926 | CS |
12 | -0.8133 | -71.3421052632 | 1.14 | 1.28 | 0.221 | 191090 | 0.71300335 | CS |
26 | -0.6633 | -67 | 0.99 | 2.77 | 0.221 | 141856 | 1.00095947 | CS |
52 | -1.4933 | -82.0494505495 | 1.82 | 2.77 | 0.221 | 112793 | 1.10217913 | CS |
156 | -47.2733 | -99.3136554622 | 47.6 | 48.8 | 0.221 | 443197 | 10.9649956 | CS |
260 | -29.2733 | -98.8962837838 | 29.6 | 62 | 0.221 | 521545 | 23.8303147 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions